Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].

Arthritis Res Ther · 2005 · PMC1174954 · PMID 15899049

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The group given risedronate at 15 mg showed a trend towards improvement from baseline values, although the differences were not statistically significant ( P values from 0.10 to 0.33).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.